Innovative AI Solutions Avenda Health's flagship product, Unfold AI, leverages advanced artificial intelligence to improve prostate cancer detection and treatment outcomes, presenting a significant opportunity for partnerships with healthcare providers seeking cutting-edge diagnostic tools.

Recognition & Awards The company's recent top Digital Health awards and recognition within the AI in Patient Health category highlight its growing industry reputation, making it an attractive collaborator for hospitals and health systems aiming to adopt innovative health technologies.

Strategic Funding With recent venture funding of 3.5 million dollars, Avenda Health is positioned for expansion and scaling of its AI-powered solutions, offering opportunities to investors and strategic partners interested in the digital health and oncology markets.

Clinical Validation Results from UCLA studies and presentations at major urological conferences demonstrate the clinical efficacy of Avenda's AI tools in tumor margin identification and focal therapy prediction, creating compelling sales propositions for urology clinics and hospital systems.

Technological Advancement The launch of AI-Assisted Robotic HIFU procedures and ongoing research positions Avenda Health as a leader in AI-driven minimally invasive cancer treatments, offering potential sales avenues with surgical centers and medical device distributors focused on innovative oncology solutions.